Description
Mechanism of Action:
✔ Inhibits SGLT2 receptors in the kidneys, preventing glucose reabsorption and increasing glucose excretion through urine.
✔ Reduces blood sugar levels without increasing insulin secretion.
✔ Lowers cardiovascular risks in patients with diabetes.
Indications:
✔ Type 2 Diabetes Mellitus
✔ Cardiovascular risk reduction in diabetic patients
✔ Chronic kidney disease management
Key Benefits:
✅ Promotes glucose excretion, reducing blood sugar levels
✅ Supports weight loss and lowers blood pressure
✅ Reduces cardiovascular disease risks
✅ Effective in patients with heart failure
Dosage & Administration:
- Recommended Dosage: 10 mg or 25 mg once daily, as prescribed.
- Route of Administration: Oral
- Food Intake: Can be taken with or without food.
Precautions & Warnings:
- Monitor kidney function before and during treatment.
- May increase risk of urinary tract infections and dehydration.
- Not suitable for patients with Type 1 Diabetes or diabetic ketoacidosis.
Possible Side Effects:
- Increased urination
- Dehydration
- Urinary and genital infections (rare)
Storage & Packaging:
- Store below 30°C in a cool, dry place.
- Available in blister packs and bulk packaging.
Manufacturing & Regulatory Compliance:
Manufactured by Aetos Life Care in WHO-GMP certified facilities, ensuring compliance with EU-GMP standards.
Global Export & Supply:
Aetos Life Care exports Empagliflozin 10 mg, 25 mg Tablets to Latin America, Africa, Asia, Europe, and CIS countries, providing high-quality and cost-effective diabetes management solutions worldwide.
